Skip to main content
Toggle navigation
Login
Home
iwCLL X / Twitter
Favorite
Tweet
Lenka Polcerova
Institute of Biostatistics and Analyses, Ltd., Brno, Czech Republic, Czech Republic
Poster(s):
1526 - Ibrutinib and acalabrutinib in the treatment of relapsed/refractory chronic lymphocytic leukemia: a real-world analysis from the Czech Chronic Lymphocytic Leukemia Patients Registry